The coalition has prepared the Statement for use in different countries to aid when advocating for the provision of anti-COVID-19 treatment and care for immunocompromised or immunosuppressed (IC/IS) blood cancer patients. The Statement has been endorsed by multiple networks and national organisations of the global patient advocacy community as well as renowned medical societies and representatives from the global clinical community.